Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.72
- Piotroski Score 5.00
- Grade Buy
- Symbol (NEO)
- Company NeoGenomics, Inc.
- Price $14.50
- Changes Percentage (-0.96%)
- Change -$0.14
- Day Low $14.45
- Day High $15.07
- Year High $21.22
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. The company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
- Last Earnings 12/15/2020
- Ex-Dividend for 5/16 Dividend 12/17/2020
- Dividend Payable 12/30/2020
- Today N/A
- Next Earnings (Estimated) 11/03/2024
- Fiscal Year End N/A
- Average Stock Price Target $19.00
- High Stock Price Target $54.00
- Low Stock Price Target $15.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.66
- Trailing P/E Ratio -19.71
- Forward P/E Ratio -19.71
- P/E Growth -19.71
- Net Income $-87,968,000
Income Statement
Quarterly
Annual
Latest News of NEO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Pennsylvania nonprofit celebrates 10 years supporting families with newborns in neonatal intensive care
"Today Is A Good Day" organization supports families with babies in NICU, offering care packages and support groups. Celebrating its 10th anniversary, they are launching a NICU family advocate program...
By CBS News | 2 days ago -
Woman sentenced to 18 years for plotting with neo-Nazi to attack Baltimore's power grid
Clendaniel and Russell planned "sniper attacks" on Maryland substations to create chaos. Clendaniel was sentenced to 18 years for conspiracy and gun charges. Raised in abusive environments, she was in...
By POLITICO | 2 days ago -
OPINION: Trump amplifies racist lies, giving neo-Nazis 'real power.' Where are GOP leaders?
The former Republican president is accused of aligning himself with neo-Nazis and white supremacists, spreading lies about Haitian immigrants in Ohio. His rhetoric has led to bomb threats and fear amo...
By USA Today | 5 days ago
